Kopran's Stock Sees Decline of -7.64%, Underperforms Sector by -4.5%

Kopran, a smallcap pharmaceutical company, has recently seen a decline in its stock price. On November 13, 2024, the company's stock lost -7.64%, underperforming the sector by -4.5%. This marks the second consecutive day of losses for Kopran, with a total decline of -10.71% in this period.

The stock's performance today was also reflected in its intraday low of Rs 273.4 (-6.78%). However, it is worth noting that Kopran's stock is still performing better than the 200 day moving average, but is lower than the 5 day, 20 day, 50 day, and 100 day moving averages.

In comparison to the overall market, Kopran's stock has underperformed. On the same day, the Sensex saw a decline of -0.84%, while Kopran's stock saw a decline of -6.99%. Similarly, in the past month, Kopran's stock has seen a decline of -6.89%, while the Sensex saw a decline of -4.14%.

MarketsMOJO has given a 'Hold' call for Kopran's stock, indicating a neutral stance on the company's performance. As a smallcap company in the pharmaceutical industry, Kopran's stock may continue to experience fluctuations in the market. Investors are advised to do their own research and make informed decisions before investing in the company.